Survivin-T34A: molecular mechanism and therapeutic potential

Nathan Wall, Aspe
  • OncoTargets and Therapy, December 2010, Taylor & Francis
  • DOI: 10.2147/ott.s15293

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/ott.s15293

The following have contributed to this page: Nathan Wall

Contributors